Kevin D. Freeman
Insider
IndividualBuying only1 10b5-1 trade
- 2024
- Jan 21, 2026
- 6
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin D. Freeman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 10X Fund, L.P. - $2.19M in GALT purchases and sales in the last 12 months
- Khurram Jamil - $1.44M in GALT purchases and sales in the last 12 months
- Jack W. Callicutt - $944K in GALT purchases and sales in the last 12 months
- Joel Lewis - $621K in GALT purchases and sales in the last 12 months
- Harold H. Shlevin - $501K in GALT purchases and sales in the last 12 months
- Kary Eldred - $3K in GALT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin D. Freeman?
Kevin D. Freeman is a corporate insider of GALECTIN THERAPEUTICS INC (GALT). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kevin D. Freeman last file a Form 4?
The most recent primary Form 4 on record is dated 21 January 2026, one of 6 filings going back to 2024.
Has Kevin D. Freeman been buying or selling stock?
Recorded transactions: 6 open-market purchases ($73K) and 0 open-market sales across all tracked filings.
